BETA

IPO registrations (S-1, F-1) · Registrants

Achaogen, Inc.

SEC CIK
1301501 · filings on EDGAR ↗
Name on the registration
Achaogen Inc
Former names
Achaogen Inc (2004–2018)
Registration
Form S-1, first filed 2014-01-24, last 2014-03-10; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 2014-03-12; declared effective 2014-03-11
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1 TOWER PLACE, SUITE 300, South San Francisco, CA 94080
EIN
68-0533693
EDGAR entity type
operating
Insiders and CEO pay
Achaogen, Inc. on the corporate pages

Offering terms

Proposed price range
$12.00–$14.00 per share (S-1/A filed 2014-03-10)
Final price
$6.19 per share, below the range (424B4 filed 2014-03-12, an initial public offering)
Shares sold
6,000,000
Gross proceeds
$37,140,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol AKAO
Lead underwriters
Credit Suisse (2,700,000 shares); Cowen (1,800,000 shares)
Syndicate
William Blair (900,000); Needham & Company (600,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 9

FiledFormWhat it isName as filedEDGAR
2014-01-24S-1S-1 (registration)Achaogen Inc0001193125-14-020548 ↗
2014-02-12S-1/AS-1/A (amendment)Achaogen Inc0001193125-14-048369 ↗
2014-02-25S-1/AS-1/A (amendment)Achaogen Inc0001193125-14-065701 ↗
2014-02-27S-1/AS-1/A (amendment)Achaogen Inc0001193125-14-071005 ↗
2014-03-10S-1/AS-1/A (amendment)Achaogen Inc0001193125-14-091160 ↗
2014-03-11S-1MEFS-1MEF (added securities)Achaogen Inc0001193125-14-094334 ↗
2014-03-11EFFECTEFFECT (declared effective)Achaogen Inc9999999995-14-000631 ↗
2014-03-12424B4424B4 (final prospectus)Achaogen Inc0001193125-14-094586 ↗
2015-04-21EFFECTEFFECT (declared effective)Achaogen Inc9999999995-15-000942 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-03-10S-1/Aregistration statement$12.00–$14.005,000,000-Nasdaq AKAO4primary document; range, shares headline, cover names 4document ↗
2014-03-12424B4final prospectus$6.196,000,000$37,140,000Nasdaq AKAO4primary document; price line, shares headline, proceeds computed, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ARCH VENTURE FUND VI LPTenPercentOwner22014
ARCH VENTURE PARTNERS VI LLCTenPercentOwner22014
ARCH VENTURE PARTNERS VI LPTenPercentOwner22014
BERTOCCI DEREK AOfficerChief Financial Officer; SVP and CFO32014–2015
BLAIR JAMES CTenPercentOwner22014
BYBEE CLINTONTenPercentOwner22014
CRANDELL KEITHTenPercentOwner22014
DOMAIN PARTERS VII L PTenPercentOwner22014
DOVEY BRIAN HTenPercentOwner22014
DOYLE JOHN CDirector62014–2018
DP VII ASSOCIATES LPTenPercentOwner22014
Filice BeckiOfficerSVP, Development Operations12014
Halak Brian KTenPercentOwner22014
Hillan KennethDirector,OfficerChief Executive Officer; President and CEO; See Remarks132014–2018
Hom DennisOfficerVP, Finance and Corp. Dev.12014
Murray ChristineOfficerVP, Regulatory Affairs22014–2015
NELSEN ROBERTTenPercentOwner22014
ROBERTS BRYAN EDirector; Director,TenPercentOwner72014–2018
ROCKLAGE SCOTT MDirector22014
Samuels Camille DDirector22014
SCHOEMAKER KATHLEEN KTenPercentOwner22014
Smither John WDirector62014–2018
TREU JESSE ITenPercentOwner22014
VEF Management IV, LLCTenPercentOwner22014
VENROCK ASSOCIATES IV L PTenPercentOwner22014
VENROCK ENTREPRENEURS FUND IV L PTenPercentOwner22014
Venrock Management IV, LLCTenPercentOwner22014
Venrock Partners, L.P.TenPercentOwner22014
Venrock Partners Management, LLCTenPercentOwner22014
Versant Affiliates Fund II-A, LPTenPercentOwner22014
Versant Side Fund II, LPTenPercentOwner22014
Versant Venture Capital II, LPTenPercentOwner22014
Versant Ventures II LLCTenPercentOwner22014
VITULLO NICOLETenPercentOwner22014
WALSH CHRISTOPHER T PHDDirector32014–2015
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUSTTenPercentOwner22014
BOERNER CHRISTOPHER S.Director22014
Friedland IanOfficerChief Medical Officer; SVP, Chief Medical Officer72014–2017
Colowick AlanDirector42015–2017
Lieginger KentDirector52015–2018
STEA GREGORYDirector52015–2018
Wise BlakeDirector,Officer; OfficerChief Executive Officer; Chief Operating Officer; President & COO; See Remarks182015–2019
Fischbach MichaelDirector52015–2018
Sarpangal ZerynOfficerChief Financial Officer; See Remarks; VP, HR and Corporate Affairs112015–2019
BARRIS PETER JTenPercentOwner22016
BASKETT FORESTTenPercentOwner22016
Florence Anthony A. Jr.TenPercentOwner22016
Growth Equity Opportunities IV, LLCTenPercentOwner22016
KOLLURI KRISHNA KITTUTenPercentOwner22016person page Fuzzy
MAKOWER JOSHUATenPercentOwner22016
MOTT DAVID MTenPercentOwner22016
NEA 15 GP, LLCTenPercentOwner22016
NEA Partners 15, L.P.TenPercentOwner22016
New Enterprise Associates 15, L.P.TenPercentOwner22016
Sakoda JonTenPercentOwner22016
SANDELL SCOTT DTenPercentOwner22016
Sonsini Peter W.TenPercentOwner32016
Viswanathan RaviTenPercentOwner22016
Weller Harry RTenPercentOwner12016
Schilke TobinOfficerChief Financial Officer92016–2018
LOEB GARYOfficerGeneral Counsel; See Remarks112016–2019
Gilbert Halley EDirector42017–2018
Swem LeeOfficerChief Scientific Officer32017–2018
Bernstein KarenDirector32017–2018
DUGGAN ROBERT WTenPercentOwner202017–2019
Dorling JanetOfficerChief Commercial Officer72018–2019
Makhzoumi MohamadTenPercentOwner12018
Puttagunta ChetanTenPercentOwner12018
Bhatt ElizabethOfficerChief Operating Officer52018–2019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2017-05-16Achaogen IncBiotechnology$9,999,976$9,999,97611
2016-06-14Achaogen IncBiotechnology$32,769,984$25,449,98781

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationACHAOGEN, INC.CAState business registriesname and state
Plan sponsorACHAOGEN INC.CAForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientACHAOGEN, INC.CAFederal spending (USAspending)name and state
Form D issuerAchaogen IncCAForm D private offeringsCIK (EXACT)
Lobbying clientACHAOGENCAFederal lobbying (LDA)name and state
Lobbying clientACHAOGENCAFederal lobbying (LDA)name and state
Lobbying clientACHAOGENCAFederal lobbying (LDA)name and state
Lobbying clientACHAOGENCAFederal lobbying (LDA)name and state
Lobbying clientACHAOGEN INCCAFederal lobbying (LDA)name and state
Lobbying clientACHAOGEN, INCCAFederal lobbying (LDA)name and state
Lobbying registrantACHAOGENCAFederal lobbying (LDA)name and state
Patent assigneeACHAOGEN, INC.CAPatents (USPTO)name and state
SEC filerAchaogen, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerAchaogen, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorACHAOGEN INC.EIN (EXACT)
Person pageKrishna Kittu KolluriPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health